Notice Pursuant to The National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium, 20488-20489 [2017-08849]

Download as PDF 20488 Federal Register / Vol. 82, No. 83 / Tuesday, May 2, 2017 / Notices T.12S., R.19E., Secs. 2, 4, 6, 8, and 10; Sec. 15, S1⁄2; Sec. 17, S1⁄2; Secs. 18 thru 22 and 27 thru 34. The area described aggregates 225,651 acres, more or less, in Imperial and Riverside Counties, California. Dated: April 26, 2017. Ryan K. Zinke, Secretary of the Interior. [FR Doc. 2017–08853 Filed 5–1–17; 8:45 am] BILLING CODE 4310–40–P notifications disclosing all changes in membership. On April 7, 2000, IMS Global filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on September 13, 2000 (65 FR 55283). The last notification was filed with the Department on February 8, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 6, 2017 (82 FR 12639). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. DEPARTMENT OF JUSTICE [FR Doc. 2017–08850 Filed 5–1–17; 8:45 am] Antitrust Division BILLING CODE P sradovich on DSK3GMQ082PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—IMS Global Learning Consortium, Inc. Notice is hereby given that, on April 19, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), IMS Global Learning Consortium, Inc. (‘‘IMS Global’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Collective Shift/LRNG, Chicago, IL; Hancom Communication, Inc., Gyeonggi-do, REPUBLIC OF KOREA; Harford County Public Schools, Bel Air, MD; ICT and Systems ˚ ˚ Development, Umea University, Umea, SWEDEN; Infinitas Learning (incl. Noordhoff Health), Houton, THE NETHERLANDS; Lee County Public Schools, Fort Meyers, FL; Mozilla, Mountain View, CA; Neosho School District, Neosho, MO; Park Hill School District, Kansas City, MO; ProExam, New York, NY; Renaissance Learning, Wisconsin Rapids, WI; Apereo Foundation (Sakai/Tsugi), Ann Arbor, MI; and Trifork Learning Solutions B.V., Amsterdam, THE NETHERLANDS, have been added as parties to this venture. Also, Newton Public Schools, Newton, MA; and Lone Star College Online, The Woodlands, TX, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and IMS Global intends to file additional written VerDate Sep<11>2014 16:36 May 01, 2017 Jkt 241001 DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Cooperative Research Group on ROS-Industrial ConsortiumAmericas Notice is hereby given that, on April 7, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Southwest Research Institute—Cooperative Research Group on ROS-Industrial Consortium-Americas (‘‘RIC-Americas’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its Membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Magna Services of America Inc., Troy, MI, and Cognex Corporation, Natick, MA, have been added as parties to this venture. In addition, Cessna Aircraft Company, a Textron Company, Wichita, KS, has withdrawn as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open and RIC-Americas intends to file additional written notifications disclosing all changes in membership or planned activities. On April 30, 2014, RIC-Americas filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 The last notification was filed with the Department on February 21, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on April 4, 2017 (82 FR 16420). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–08852 Filed 5–1–17; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to The National Cooperative Research and Production Act of 1993—Medical CBRN Defense Consortium Notice is hereby given that, on April 10, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical CBRN Defense Consortium (‘‘MCDC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Codagenix, Inc., Great Neck, NY; Fraunhofer USA Center for Molecular Biotechnology, Newark, DE; FUJIFILM Pharmaceuticals USA, Inc., Boston, MA; Ibis Biosciences Inc., an Abbott Company, Carlsbad, CA; Biomeme, Inc., Philadelphia, PA; PPD Development LP, Wilmington, NC; California Institute for Biomedical Research, La Jolla, CA; Leidos, Inc., Reston, VA; Merck Research Laboratories, Whitehouse Station, NJ; Tetracore, Inc., Rockville, MD; Mesa Tech International, San Diego, CA; Synthetic Genomics Vaccines, Inc., La Jolla, CA; Brimrose Technology Corporation, Sparks, MD; Bioo Scientific Corporation, Austin, TX; Click Diagnostics, Inc., San Jose, CA; Pulmotect, Inc., Houston, TX; JYANT Technologies, Inc., Marietta, GA; YourEncore, Inc., Indianapolis, IN; and Texas Biomedical Research Institute, San Antonio, TX, have been added as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership. E:\FR\FM\02MYN1.SGM 02MYN1 Federal Register / Vol. 82, No. 83 / Tuesday, May 2, 2017 / Notices On November 13, 2015, MCDC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 6, 2016 (81 FR 513). The last notification was filed with the Department on February 3, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on March 7, 2017 (82 FR 12847). BILLING CODE P DEPARTMENT OF JUSTICE BILLING CODE P DEPARTMENT OF JUSTICE Executive Office for Immigration Review, Department of Justice. ACTION: 60-day notice. AGENCY: Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—PXI Systems Alliance, Inc. sradovich on DSK3GMQ082PROD with NOTICES [FR Doc. 2017–08851 Filed 5–1–17; 8:45 am] Agency Information Collection Activities; Proposed Collection; Comments Requested; Notice of Entry of Appearance as Attorney or Representative Before the Board of Immigration Appeals [FR Doc. 2017–08849 Filed 5–1–17; 8:45 am] Notice is hereby given that, on April 12, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), PXI Systems Alliance, Inc. (‘‘PXI Systems’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Instrumental Systems Corp., Moscow, RUSSIA; Sundance Digital Signal Processing, Inc., Reno, NV; and Circuit Check, Inc., Maple Grove, MN, have been added as parties to this venture. Also, Meilhaus Electric GmbH, Alling, GERMANY; and Acquisys, Voisins le Bretonneux, FRANCE, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems intends to file additional written notifications disclosing all changes in membership. On November 22, 2000, PXI Systems filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 8, 2001 (66 FR 13971). The last notification was filed with the Department on December 15, 2016. 16:36 May 01, 2017 Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [OMB Number 1125–0005] Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. VerDate Sep<11>2014 A notice was published in the Federal Register pursuant to Section 6(b) of the Act on January 11, 2017 (82 FR 3360). Jkt 241001 The Department of Justice (DOJ), Executive Office for Immigration Review (EOIR), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 60 days until July 3, 2017. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Jean King, General Counsel, USDOJ– EOIR–OGC, Suite 2600, 5107 Leesburg Pike, Falls Church, Virginia 20530; telephone: (703) 305–0470. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the SUMMARY: PO 00000 Frm 00034 Fmt 4703 Sfmt 9990 20489 information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection: 1. Type of Information Collection: Revision and extension of a currently approved collection. 2. The Title of the Form/Collection: Notice of Entry of Appearance as Attorney or Representative Before the Board of Immigration Appeals. 3. The agency form number: EOIR–27 (OMB #1125–0005). 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Attorneys or representatives notifying the Board of Immigration Appeals (Board) that they are representing a party in proceedings before the Board. Other: None. Abstract: This information collection is necessary to allow an attorney or representative to notify the Board that he or she is representing a party before the Board. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 20,669 respondents will complete each form within approximately 6 minutes. 6. An estimate of the total public burden (in hours) associated with the collection: 2,066 annual burden hours. If additional information is required contact: Melody D. Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., 3E.405B, Washington, DC 20530. Dated: April 27, 2017. Melody D. Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2017–08821 Filed 5–1–17; 8:45 am] BILLING CODE 4410–30–P E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 82, Number 83 (Tuesday, May 2, 2017)]
[Notices]
[Pages 20488-20489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08849]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to The National Cooperative Research and 
Production Act of 1993--Medical CBRN Defense Consortium

    Notice is hereby given that, on April 10, 2017, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense Consortium 
(``MCDC'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing changes in 
its membership. The notifications were filed for the purpose of 
extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, Codagenix, Inc., Great Neck, NY; Fraunhofer USA Center 
for Molecular Biotechnology, Newark, DE; FUJIFILM Pharmaceuticals USA, 
Inc., Boston, MA; Ibis Biosciences Inc., an Abbott Company, Carlsbad, 
CA; Biomeme, Inc., Philadelphia, PA; PPD Development LP, Wilmington, 
NC; California Institute for Biomedical Research, La Jolla, CA; Leidos, 
Inc., Reston, VA; Merck Research Laboratories, Whitehouse Station, NJ; 
Tetracore, Inc., Rockville, MD; Mesa Tech International, San Diego, CA; 
Synthetic Genomics Vaccines, Inc., La Jolla, CA; Brimrose Technology 
Corporation, Sparks, MD; Bioo Scientific Corporation, Austin, TX; Click 
Diagnostics, Inc., San Jose, CA; Pulmotect, Inc., Houston, TX; JYANT 
Technologies, Inc., Marietta, GA; YourEncore, Inc., Indianapolis, IN; 
and Texas Biomedical Research Institute, San Antonio, TX, have been 
added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MCDC intends to file additional 
written notifications disclosing all changes in membership.

[[Page 20489]]

    On November 13, 2015, MCDC filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
January 6, 2016 (81 FR 513).
    The last notification was filed with the Department on February 3, 
2017. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on March 7, 2017 (82 FR 12847).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-08849 Filed 5-1-17; 8:45 am]
 BILLING CODE P